Zeto, Inc.

Zeto, Inc. manufactures rapid, gel-free, portable EEG headset systems for point-of-care neurological diagnostics. The company's primary product line includes Zeto ONE, a full-montage EEG system for ICU, emergency departments, and EMS transport, and Zeto New Wave™, a streamlined outpatient EEG solution for clinics. Both systems feature wireless, battery-powered operation with no skin preparation required and soft-tip electrodes that leave no residue. Zeto's platform includes a HIPAA-compliant cloud-based software suite with real-time remote video viewing, collaborative review tools, and an integrated report generator. The company offers optional EEG reading services performed by board-certified neurologists. Zeto has also launched NeuroPulse™, an AI-powered software tool for seizure burden and status epilepticus detection using full 10-20 montage EEG in collaboration with encevis. The system is designed to reduce operator training burden by enabling non-specialist staff to perform acquisition while maintaining diagnostic-quality full-montage recordings. Zeto's customer base includes 200+ healthcare facilities, hospitals, neuroscience research labs, clinical trials sites, and neurofeedback centers. The company supports multiple research initiatives through collaborations with universities including Vanderbilt, University of North Carolina, UT Austin, and Baylor University. Primary market segments include acute care (ICU, emergency), outpatient neurology clinics, research institutions, and underserved healthcare settings seeking rapid EEG access.